Everhope Oncology

What Everhope Oncology does

Everhope Oncology is an India-based precision oncology startup founded in March 2025 as a joint venture with Narayana Health and backed by a $10 million day-zero seed investment from W Health Ventures Fund II. The company operates two physical cancer treatment centers in Gurugram (Sector 65 and Sector 14, co-located at Kalyani Hospital) and offers an integrated care portfolio spanning chemotherapy, immunotherapy, targeted therapy, hormonal therapy, surgical oncology, interventional radiology, palliative care, and a dedicated Oncology Nutrition Program, supported by an oncologist-curated supplements e-commerce storefront.

Its clinical core is a precision oncology platform that combines comprehensive genomic profiling (NGS panels), gene-level mutation testing (EGFR, ALK, KRAS, BRCA, HER2), immunotherapy biomarker testing (PD-L1, MSI, TMB), liquid biopsy, and germline testing, with treatment decisions synthesized by a 12-member organ-specific tumor board. The go-to-market is a direct-to-patient model: physician referrals, oncologist-led consultations, walk-ins, telemedicine for follow-ups, and a dedicated international patient desk serving patients from 25+ countries with visa, travel, and accommodation coordination.

Revenue is generated primarily from individualized outpatient cancer treatment plans (priced per protocol and covered by major government and private insurers with No-Cost EMI options), ancillary diagnostic and genomic testing services, a subscription-based Oncology Nutrition Program, supplements e-commerce sales, and international patient facilitation fees. The company positions itself as a precision-led alternative to standard one-size-fits-all oncology, but as of the available data it is pre-revenue at scale, with a small employee base and a footprint limited to Gurugram.

Name

Everhope Oncology

Legal name

Everhope Oncology Private Limited

Website

https://everhope.care

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

11–50 employees

Short description

Everhope Oncology is an India-based precision oncology operator founded in March 2025 as a joint venture with Narayana Health, delivering genomic profiling-guided cancer treatment across two Gurugram centers and serving patients domestically and from 25+ countries.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Medical and Diagnostic Laboratories (62151)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)

Keywords

• Precision oncology services
• Cancer treatment center
• Genomic profiling
• Oncology diagnostics
• Chemotherapy services

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Cancer Treatment Services: Revenue is generated from outpatient cancer treatment services including chemotherapy, immunotherapy, targeted therapy, hormonal therapy, and surgical oncology delivered at Everhope's cancer centers in Gurugram. Treatment pricing is individualized based on the treatment plan developed by the tumor board.
2. Diagnostic and Precision Oncology Testing: Revenue from genomic profiling, biomarker testing, liquid biopsy, and germline genetic testing services, which guide personalized treatment planning.
3. Oncology Nutrition Consultations: Personalized nutrition consultations and programs designed for cancer patients during and after treatment, delivered virtually and coordinated with oncology treatment plans.
4. Cancer Supplements Store: Sale of oncologist-curated nutritional supplements through the company's e-commerce storefront (store.everhope.care).
5. International Patient Services: Coordination and facilitation services for international patients including visa assistance, travel arrangements, accommodation, and treatment coordination.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels6 records

Core offering

Everhope Oncology operates physical cancer treatment centers in Gurugram, India, delivering precision oncology care that combines comprehensive genomic profiling, biomarker testing, liquid biopsy and germline testing with multidisciplinary tumor board review to design personalized treatment plans. Core treatment offerings include chemotherapy, immunotherapy, targeted therapy, hormonal therapy, surgical oncology and interventional radiology, complemented by an oncology nutrition program, palliative care, financial counseling and international patient facilitation services.

Product overview

Everhope Oncology operates as a comprehensive cancer care platform offering a multi-service portfolio centered around precision oncology. The core platform combines genomic and molecular profiling with multidisciplinary tumor boards to deliver personalized cancer treatment. The treatment portfolio includes chemotherapy, immunotherapy, targeted therapy, hormonal therapy, surgical oncology, and interventional radiology. Supporting services include an Oncology Nutrition Program, Cancer Diagnostics, Cancer Screening, Palliative Care, Financial Support, and International Patient Services. The company also operates a Cancer Supplements e-commerce store. All services are delivered through their Gurugram-based centers, with treatment plans designed by a team of 12 organ-specific specialists.

Differentiator

Problem solved

Functional benefit

Products and services

• Chemotherapy Systemic drug therapy administered in private chemo suites at Everhope's Gurugram centers to stop or slow the growth of cancer cells, delivered to adult cancer patients under oncology specialist supervision.
• Immunotherapy Treatment that harnesses the patient's immune system to recognize and fight cancer, guided by PD-L1, MSI and TMB biomarker testing, delivered to patients at Everhope centers.
• Targeted Therapy Precision drugs that attack specific molecular targets within cancer cells, selected based on genomic profiling results such as EGFR, ALK, KRAS, BRCA and HER2 mutation testing.
• Hormonal Therapy Treatment that blocks hormones fueling certain cancers such as breast and prostate cancer, guided by hormonal analysis, delivered to oncology patients.
• Precision Oncology Genomic profiling-based program tailoring treatment to each patient's tumor biology, integrating NGS panels, mutation testing, immunotherapy biomarkers, liquid biopsy and germline testing into a tumor-board-reviewed plan.
• Surgical Oncology Expert surgical removal of tumors with a focus on preserving function, including robotic and nerve-sparing urological cancer procedures, delivered to cancer patients.
• Cancer Diagnostics

Quantifiable outcome

• Precision oncology improves response rates and reduces exposure to ineffective therapies and unnecessary toxicity compared to standard protocols.
• +2 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

One partnership is on record.

• Narayana HealthcoreStrategic or Co-development Partner · 1 March 2025Narayana Health is the co-development partner in the Everhope Oncology joint venture. Everhope was built in partnership with Narayana Health to address gaps in quality cancer care delivery in India. The venture focuses on modernizing cancer care through diagnostics, standardized protocols, and AI-assisted treatment guidelines.

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• HealthCare Global Enterprises (HCG): India's largest dedicated cancer hospital chain, operating 20+ cancer centers across India with medical, surgical, and radiation oncology. Most directly comparable to Everhope as a multi-site oncology specialty provider, though at much greater scale and maturity.
• Cytecare Cancer Hospitals: Bengaluru-based cancer specialty hospital chain offering precision oncology and multidisciplinary tumor boards. Directly comparable in service mix (precision diagnostics + treatment) and India-focused outpatient/specialty model.
• American Oncology Institute (AOI): Network of cancer specialty centers across India operated with US oncology protocols (CTSI). Comparable specialty-hospital model with medical, surgical, and radiation oncology under one roof.
• MedGenome: India- and US-headquartered precision oncology diagnostics company offering NGS-based genomic profiling, liquid biopsy, and biomarker testing. Directly comparable technology and diagnostic offering, though B2B/research-focused rather than patient-facing.
• Strand Life Sciences: India-based genomics and precision medicine company offering comprehensive genomic profiling for oncology. Comparable diagnostic technology stack and India footprint, with broader bioinformatics capabilities.

Broad incumbents

• Apollo Hospitals: India's largest private hospital chain with comprehensive oncology programs across multiple cities. Competes broadly with Everhope for oncology patients, but oncology is one division within a much larger multi-specialty portfolio.
• Max Healthcare: Leading North India hospital chain with established oncology centers in Delhi-NCR, including advanced precision medicine and bone marrow transplant programs. Geographic overlap with Everhope's Gurugram base is direct.
• Fortis Healthcare: Pan-India hospital chain with significant oncology offerings and advanced treatment modalities. Competes for both domestic and medical-tourism oncology patients; broader portfolio dilutes pure-play oncology comparison.
• Tata Medical Center: Premier non-profit cancer specialty hospital in Kolkata affiliated with Tata Trust. Comparable mission focus on precision, multi-disciplinary oncology; serves as the gold-standard Indian oncology brand Everhope must benchmark against.

Others

• Narayana Health: Strategic JV partner and co-investor in Everhope; also operates its own cancer care programs across India. Most thematically connected peer — shared economics, clinical DNA, and governance — but separate operating entity.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@everhopeoncology
• LinkedInlinkedin.com/company/everhope-oncology
• Instagraminstagram.com/everhope.care

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Everhope Oncology